CIPLA DONEPEZIL donepezil hydrochloride (as monohydrate) 5 mg film-coated tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

donepezil hydrochloride monohydrate, Quantity: 5.21 mg (Equivalent: donepezil hydrochloride, Qty 5.21 mg)

MAH:

Cipla Australia Pty Ltd

INN:

donepezil hydrochloride monohydrate

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: lactose monohydrate; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000

administration_route:

Oral

units_in_package:

28 tablets, 14 tablets, 7 tablets

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

CIPLA DONEPEZIL (donepezil hydrochloride) is indicated for the treatment of mild, moderate and severe Alzheimer's disease.

leaflet_short:

Visual Identification: White coloured circular, biconvex film-coated tablets with "5" debossed on one side and "DPZ" debossed on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2015-12-18